Nivolumab/Ipilimumab vs. Chemo in High TMB Advanced NSCLC: Key Results from CheckMate 227

Dr. Jack West reviews the CheckMate 227 trial, summarizing highlights from efficacy & side effects of nivolumab/ipilimumab (nivo/ipi) compared to standard doublet chemotherapy in patients with adv... Author: BeaconMedIC Added: 05/09/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts